Advertisement

Topics

Human medicines European public assessment report (EPAR): Copalia HCT, amlodipine / valsartan / hydrochlorothiazide, Revision: 11, Authorised

13:24 EDT 13 Jun 2018 | European Medicines Agency

Original Article: Human medicines European public assessment report (EPAR): Copalia HCT, amlodipine / valsartan / hydrochlorothiazide, Revision: 11, Authorised

NEXT ARTICLE

More From BioPortfolio on "Human medicines European public assessment report (EPAR): Copalia HCT, amlodipine / valsartan / hydrochlorothiazide, Revision: 11, Authorised"

Advertisement
Quick Search
Advertisement
Advertisement